๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Ovary Neoplasm

Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites๐Ÿ“ Los Angeles๐Ÿ“ Rochester University of Southern California ยท Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice NCT06103916n/a1 site๐Ÿ“ Veldhoven Maxima Medical Center ยท Tests: Observational study. Prospective registration of ultrasound data in patients with ovarian tumors for which an ultrasounโ€ฆ Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy NCT07361471NA1 site๐Ÿ“ Clermont-Ferrand Centre Jean Perrin ยท Tests: molecular analysis ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients NCT06844136n/a1 site๐Ÿ“ Liverpool Pierian Biosciences ยท Tests: No intervention A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi NCT05551208Phase 21 site๐Ÿ“ Chongqing Chongqing University Cancer Hospital ยท Tests: fluzopanib and bevacizumab A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site๐Ÿ“ Shanghai Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-B01D1 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers NCT03564340Phase 1, Phase 254 sites๐Ÿ“ Birmingham๐Ÿ“ Boston๐Ÿ“ Boston Regeneron Pharmaceuticals ยท Tests: Ubamatamab, Cemiplimab, Sarilumab, Tocilizumab Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy NCT07144826EARLY Phase 11 site๐Ÿ“ Columbus Ohio State University Comprehensive Cancer Center ยท Tests: Biospecimen Collection, Placebo Administration, Probiotic, Questionnaire Administration Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries NCT05769517n/a1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Germinal BRCA A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NCT04686682Phase 1, Phase 21 site๐Ÿ“ Tianjin Jacobio Pharmaceuticals Co., Ltd. ยท Tests: JAB-8263, JAB-8263 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites๐Ÿ“ Beverly Hills๐Ÿ“ San Francisco๐Ÿ“ Westwood, Los Angeles Fore Biotherapeutics ยท Tests: Plixorafenib 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 18F-T2 PET/CT A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer NCT06840002Phase 1, Phase 21 site๐Ÿ“ Wuhan Suzhou Suncadia Biopharmaceuticals Co., Ltd. ยท Tests: SHR-A1811, Carboplatin, Bevacizumab, Oxaliplatin for Injection, Paclitaxel injection IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome NCT05756023NA1 site๐Ÿ“ Asyut Egymedicalpedia ยท Tests: the pregnancy rate at IVF / ICSI cycles Brown Adipose Tissue Modulation in Polycystic Ovary Syndrome Using Infrared Thermography NCT07896642NA2 sites๐Ÿ“ Istanbul๐Ÿ“ Istanbul Istanbul Health and Technology University ยท Tests: inositol A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) NCT05429970NA7 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Mind-body resilience training, Music therapy, Propranolol, Etodolac Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer NCT05761561NA2 sites๐Ÿ“ New Haven๐Ÿ“ Miami Yale University ยท Tests: Exercise and medical nutrition A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors NCT05932862Phase 116 sites๐Ÿ“ Fountain Valley๐Ÿ“ Jacksonville๐Ÿ“ Orlando Exelixis ยท Tests: XL309, Olaparib Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors NCT06646627Phase 11 site๐Ÿ“ Palo Alto Stanford University ยท Tests: B7-H3CART Performance of SYMMCORAยฎ vs. V-Locยฎ Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy NCT06024109n/a2 sites๐Ÿ“ Frankfurt am Main๐Ÿ“ Manresa Aesculap AG ยท Tests: Closure of the Vaginal Cuff after Total Hysterectomy Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism NCT00929006EARLY Phase 11 site๐Ÿ“ Charlottesville University of Virginia ยท Tests: Micronized progesterone suspension, Placebo Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer NCT07023484Phase 26 sites๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen๐Ÿ“ Chai Wan The University of Hong Kong ยท Tests: KELIM, Carboplatin plus Paclitaxel, Interval debulking surgery A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration NCT06564428n/a1 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: Suspective gene mutations and family history A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer NCT07532434n/a1 site๐Ÿ“ Beijing Peking University Third Hospital GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer NCT07489287Phase 11 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: GB-5267 - IV only, GB-5267 -Combined IV and IP Infusion A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan RC48 in Combination With AK104 and Bevacizumab in OCCC NCT06540729Phase 21 site๐Ÿ“ Guanzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: Disitamab vedotin in combination with AK104 and bevacizumab for the treatment of recurrent and persistent clear cell ovโ€ฆ Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer NCT06543537NA1 site๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Collaborative Agenda-Setting Intervention A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. NCT07389239Phase 1, Phase 21 site๐Ÿ“ Chicago University of Chicago ยท Tests: Decitabine, Cyclophosphamide Conditioning, NY-ESO-1 TCR/ dnTGFฮฒRII, Aldesleukin
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy